Lower riskDrug recall · FDA · Published August 25, 2026
Ajanta Pharma Fluphenazine Tablets Recall: Impurity Risk in 100-Count Bottles
Ajanta Pharma recalls 100-count Fluphenazine Hydrochloride tablets due to impurity levels exceeding safety limits. Affected lots have specific expiration dates and are prescription-only.
Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.
“Ajanta Pharma Fluphenazine Tablets Recall: Impurity Risk in 100-Count Bottles.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/1004686-ajanta-pharma-fluphenazine-tablets-recall-impurity-risk-in-100-count. Based on FDA recall #D-0836-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0836-2026%22&limit=1).
The FDA announced on August 25, 2026, that Ajanta Pharma USA Inc. is recalling Fluphenazine Hydrochloride Tablets, USP, 1mg, due to failed impurity specifications. The agency issued recall number D-0836-2026 for the voluntary Class III action.
Lot codes: DJ23254 (Exp. Date 11/30/2026), DJ10205 (Exp. Date 04/30/2027)
Quantity: 403,200 tablets
The hazard
The tablets failed impurity specifications because Organic Impurities by HPLC (Impurity-A) tested at 1.1 percent during 18-month long-term stability testing, exceeding the 1.0 percent specification limit according to the FDA.
Context
GovInfoNow's records show Ajanta Pharma USA Inc. has two other recalls on record since May 27, 2026, including a May 28, 2026 recall of Fenofibrate Capsules for CGMP deviations and a May 27, 2026 recall of Aripiprazole Tablets due to a mix-up with Voriconazole. Other recent recalls of similar products include an April 29, 2026 recall of Duloxetine capsules due to potential impurity risk and a June 1, 2026 recall of Sun Pharmaceutical Fexofenadine 180mg Tablets for impurities.
How to tell if you have this one
Check for the product name 'Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles' with lot numbers DJ23254 (expiring 11/30/2026) or DJ10205 (expiring 04/30/2027).
Brand
Ajanta Pharma
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the lot number and expiration date on the bottle to see if it matches the recalled lots.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide within the U.S” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 22 days after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0836-2026 (August 25, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0836-2026 to see it in context.
Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.